FDA Approves Tindamax(R) For Bacterial Vaginosis (Medical News Today)
Mission Pharmacal today announced that the U.S. Food and Drug Administration (FDA) approved Tindamax(R) (tinidazole) for the treatment of bacterial vaginosis (BV), the most common vaginal infection among women of childbearing age in the United States. [click link for full article]

FDA to Stop Sales of Unapproved Timed-Release Cold Medications (HealthDay via Yahoo! News)
FRIDAY, May 25 (HealthDay News) -- The U.S. Food and Drug Administration said Friday that it plans to stop companies from marketing unapproved products that contain the cold treatment guaifenesin in unapproved timed-release form.

A Costly Trade with China (The Epoch Times)
A May 24 U.S. Food and Drug Administration (FDA) press release warns of monkfish-also called puffer fish-laced with the deadly toxin Tetrodotoxin, which survives even cooking or freezing, imported ...